Both Semaglutide and this treatment represent new approaches to managing glucose control, and increasingly, obesity. It is a combined receptor activator that targets multiple receptors involved in blood sugar control: https://royalbookmarking.com/story22137178/understanding-tirzepatide-mounjaro-a-thorough-explanation